Showing 2,061 - 2,080 results of 14,400 for search '(( significant increase decrease ) OR ( significant ((role decrease) OR (fold decrease)) ))', query time: 0.49s Refine Results
  1. 2061

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
  2. 2062

    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
  3. 2063
  4. 2064
  5. 2065
  6. 2066
  7. 2067
  8. 2068
  9. 2069
  10. 2070
  11. 2071
  12. 2072
  13. 2073

    Fig 4 - by Qingsong Zhang (3353270)

    Published 2024
    Subjects:
  14. 2074
  15. 2075
  16. 2076
  17. 2077
  18. 2078
  19. 2079
  20. 2080